A Metabolism-Driven Prognostic Model and PSMD14–SP1–GYS1 Axis Reveal Therapeutic Vulnerabilities in Melanoma
Open Access
- 17 September 2025
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (4) , 1074-1088.e5
Abstract
No abstract availableKeywords
Funding Information
- Jiangsu Provincial Medical Center (YNRCZN0310)
This publication has 39 references indexed in Scilit:
- Adjuvant immunotherapy for melanoma patients: progress and opportunitiesESMO Open, 2024
- Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analysesCancer Letters, 2023
- Cutaneous melanomaThe Lancet, 2023
- Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanomaCancer Cell, 2022
- Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironmentSeminars in Cancer Biology, 2019
- Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial DependenceCell, 2019
- Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology ImagesCell Reports, 2018
- Transcriptional Addiction in CancerCell, 2017
- UVA-Irradiation Induces Melanoma Invasion via the Enhanced Warburg EffectJournal of Investigative Dermatology, 2016
- Therapy for cutaneous melanoma: An updateJournal of the American Academy of Dermatology, 1990